About ARPO

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company's lead compound, AKB-9778, is a small molecule activator of the Tie2 pathway and is in clinical development for the treatment of non-proliferative diabetic retinopathy.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ARPO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
VTI Vanguard Total Stock Market ETF 116.3 B 1.163E+11 3,604 3604 0.0% 0 118 K 118435
VXF Vanguard Extended Market ETF 7.1 B 7.1E+09 3,265 3265 0.0% 0 32 K 31905
ITOT iShares Core S&P Total U.S. Stock Market ETF 21.6 B 2.1559E+10 3,563 3563 0.0% 0 84 K 83509
IWC iShares Microcap ETF 852.0 M 8.5203E+08 1,396 1396 0.01% 0.0001 48 K 47569